In certain types of cancers, the eIF3d and eIF4G2 driven mechanism is also used to bypass the global sequestration of eIF4E, thereby allowing EMT, which is a crucial indicator for cancer progression to occur (17). This evidence concerns the gene EIF3D and cancer.